Whitney Ijem Analyst Performance

Managing Director at Canaccord Genuity Group

Whitney Ijem is a stock analyst at Canaccord Genuity Group in the healthcare sector, covering 33 publicly traded companies. Over the past year, Whitney Ijem has issued 62 stock ratings, including buy and hold recommendations. While full access to Whitney Ijem's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Whitney Ijem's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
113 Last 10 Years
Buy Recommendations
89.19% 99 Buy Ratings
Companies Covered
33 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy89.2%99 ratings
Hold10.8%12 ratings
Sell0.0%0 ratings

Out of 111 total stock ratings issued by Whitney Ijem at Canaccord Genuity Group, the majority (89.2%) have been Buy recommendations, followed by 10.8% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
33 companies

Whitney Ijem, an analyst at Canaccord Genuity Group, currently covers 33 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
33 companies
100.0%

Whitney Ijem of Canaccord Genuity Group specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
28 companies
84.8%
PHARMACEUTICALS
4 companies
12.1%
HEALTHCARE EQUIPMENT & SUPPLIES
1 company
3.0%

Whitney Ijem's Ratings History at Canaccord Genuity Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
11/16/2026Boost Price Target$163.69$314.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/9/2026Boost Price Target$174.15$243.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
11/4/2026Lower Price Target$17.16$34.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
11/4/2026Lower Price Target$27.79$78.00Buy
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
11/2/2026Boost Price Target$74.95$108.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
11/2/2026Lower Price Target$165.00$323.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
10/29/2026Boost Price Target$29.29$79.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
10/29/2026Boost Price Target$12.13$41.00Buy
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
10/19/2026Initiated Coverage$27.53$75.00Buy
Quoin Pharmaceuticals, Ltd. Sponsored ADR stock logo
QNRX
Quoin Pharmaceuticals
10/19/2026Initiated Coverage$3.90$18.00Buy
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
10/19/2026Initiated Coverage$29.70$75.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
9/23/2026Set Price Target$11.26$38.00
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/18/2026Boost Price Target$14.50$39.00Buy
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
9/4/2026Initiated Coverage$171.09$303.00Buy
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
9/4/2026Initiated Coverage$193.61$303.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
9/3/2026Lower Price Target$26.53$37.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/20/2026Boost Price Target$25.26$83.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
8/12/2026Lower Price Target$37.08$166.00Buy
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
8/12/2026Boost Price Target$84.15$106.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
8/11/2026Set Price Target$1.77$4.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
8/10/2026Boost Price Target$63.81$114.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
8/5/2026Set Price Target$108.89$154.00
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/4/2026Boost Price Target$470.72$442.00Hold
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
8/3/2026Boost Price Target$9.82$38.00Buy
Tenax Therapeutics, Inc. stock logo
TENX
Tenax Therapeutics
7/28/2026Initiated Coverage$16.19$35.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
6/16/2026Boost Price Target$89.70$151.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
6/16/2026Reiterated Rating$13.65$49.00Buy
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
6/3/2026Initiated Coverage$63.88$104.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
5/27/2026Lower Price Target$1.34$11.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/22/2026Lower Price Target$53.59$111.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
5/12/2026Lower Price Target$14.42$49.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
5/7/2026Boost Price Target$94.42$143.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
5/7/2026Boost Price Target$54.12$116.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
5/5/2026Lower Price Target$429.85$436.00Hold
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
4/30/2026Lower Price Target$425.67$437.00Hold
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
4/30/2026Lower Price Target$7.06$43.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
4/28/2026Boost Price Target$13.42$58.00Buy
Pharming Group N.V. Sponsored ADR stock logo
PHAR
Pharming Group
4/10/2026Initiated Coverage$16.98$37.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
4/6/2026Boost Price Target$4.70$17.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
4/6/2026Lower Price Target$21.12$180.00Buy
The investigation Porter spent tens of thousands to document (Ad)

Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel

Watch the full investigation and decide for yourself
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3/26/2026Reiterated Rating$5.62$96.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/17/2026Initiated Coverage$2.33$12.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/10/2026Boost Price Target$14.12$52.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
3/5/2026Lower Price Target$7.19$21.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
3/4/2026Lower Price Target$8.23$23.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
3/3/2026Lower Price Target$13.94$48.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
3/2/2026Lower Price Target$93.65$140.00Buy
Neurogene Inc. stock logo
NGNE
Neurogene
2/27/2026Initiated Coverage$25.04Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/26/2026Boost Price Target$60.22$104.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
2/20/2026Initiated Coverage$27.88$74.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
2/20/2026Initiated Coverage$27.59$74.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
2/18/2026Lower Price Target$20.37$79.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/17/2026Boost Price Target$485.29$441.00Hold
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/17/2026Boost Price Target$314.00$429.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
2/3/2026Boost Price Target$13.43$43.00Buy
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
1/20/2026Upgrade$54.59$98.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
12/19/2025Reiterated Rating$27.12$96.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
12/18/2025Lower Price Target$0.67$5.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
12/16/2025Boost Price Target$88.98$204.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
12/12/2025Boost Price Target$115.35$141.00Buy
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
12/8/2025Boost Price Target$18.53$40.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
11/21/2025Boost Price Target$16.50$96.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
11/13/2025Boost Price Target$80.96$148.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
11/10/2025Boost Price Target$97.65$114.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
10/9/2025Boost Price Target$74.85$90.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
8/19/2025Boost Price Target$49.50$66.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
8/18/2025Boost Price Target$6.29$10.00Buy
Passage Bio, Inc. stock logo
PASG
Passage Bio
8/14/2025Lower Price Target$7.06$67.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8/14/2025Lower Price Target$11.77$72.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/8/2025Lower Price Target$27.54$128.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/6/2025Lower Price Target$386.10$411.00Hold
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
8/4/2025Initiated Coverage$8.63$19.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
8/1/2025Boost Price Target$395.69$415.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
7/25/2025Lower Price Target$3.19$10.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
7/18/2025Boost Price Target$90.36$105.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
6/3/2025Boost Price Target$2.79$11.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
6/3/2025Lower Price Target$2.77$11.00Buy
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
6/3/2025Lower Price Target$7.16$54.00Buy
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
5/16/2025Boost Price Target$2.56$9.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
5/16/2025Lower Price Target$21.61$52.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
5/13/2025Lower Price Target$12.65$66.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
5/12/2025Lower Price Target$7.29$34.00Buy
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
4/15/2025Initiated Coverage$11.94$144.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
4/8/2025Boost Price Target$54.96$92.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/21/2025Boost Price Target$282.02$390.00Buy
Generation Bio Co. stock logo
GBIO
Generation Bio
3/17/2025Reiterated Rating$4.84$90.00Buy
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
3/13/2025Lower Price Target$0.64$6.00Buy
Arcturus Therapeutics Holdings Inc. stock logo
ARCT
Arcturus Therapeutics
3/10/2025Lower Price Target$13.98$68.00Buy
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
3/3/2025Lower Price Target$9.45$36.00Buy
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
2/27/2025Boost Price Target$53.12$81.00Buy
Unbelievable…Congress is About to Do What? (Ad)

Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washington is set to take place by November 30th. He believes it could create one of the most chaotic environments in America's history. He predicts those who understand what's happening could do very well over the next 12-18 months, while others may face steep losses. Rickards outlines the five steps he recommends.tc pixel

Click here to see Jim Rickards' five recommended steps before November 30.
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/26/2025Reiterated Rating$18.90$39.00Buy
Palvella Therapeutics, Inc. stock logo
PVLA
Palvella Therapeutics
2/20/2025Initiated Coverage$20.97$39.00Buy
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
2/18/2025Boost Price Target$42.49$136.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/18/2025Boost Price Target$256.45$385.00Buy
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
2/11/2025Upgrade$458.84$424.00Hold